Nasdaq moves to delist X3 Holdings (XTKG) after minimum bid price breach
Rhea-AI Filing Summary
X3 Holdings Co., Ltd. reported that Nasdaq has issued a determination letter to delist the company’s securities from The Nasdaq Capital Market after its share price stayed below $1 for 32 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2) on minimum bid price.
The company had previously carried out a one-for-six reverse stock split on December 30, 2025, which under Nasdaq Listing Rule 5810(c)(3)(A)(iv) makes it ineligible for a new 180‑day grace period. Nasdaq’s letter states that, absent an appeal, trading would be suspended on February 19, 2026 and a Form 25‑NSE would be filed to remove the securities from listing and registration.
X3 Holdings has requested a hearing before a Nasdaq Hearings Panel, which stays the suspension and delisting process while the Panel considers the matter. The company is evaluating options to regain compliance but warns there is no assurance that an appeal or any remedial steps will succeed.
Positive
- None.
Negative
- Nasdaq delisting determination: Nasdaq has decided to delist X3 Holdings’ securities from The Nasdaq Capital Market after a prolonged minimum bid price violation and ineligibility for a new compliance period following a recent reverse stock split.
- Listing status uncertainty: While a requested hearing temporarily stays suspension and delisting, the company explicitly notes there is no assurance of a successful appeal or eventual return to full Nasdaq compliance.
Insights
Nasdaq has moved to delist X3 Holdings after a failed minimum bid price cure.
Nasdaq determined that X3 Holdings no longer meets the $1 minimum bid price requirement after its stock traded below that level for 32 consecutive business days. Because the company completed a one-for-six reverse stock split on December 30, 2025, it is not eligible for the usual 180‑day compliance window.
The letter therefore states that Nasdaq intends to delist the securities from The Nasdaq Capital Market. X3 Holdings has requested a hearing before a Nasdaq Hearings Panel, which pauses the suspension and Form 25‑NSE filing while the Panel reviews the case. Outcomes could range from extended time to regain compliance to confirmation of delisting.
The company highlights that there is no assurance it will pursue or win any appeal or ultimately regain compliance with Nasdaq’s listing rules. Loss of a Nasdaq listing can materially affect liquidity and investor access, so the Panel’s decision and any future bid‑price remediation actions will be key for shareholders.